BLUEPRINT MEDICINES CORP earnings per share and revenue

2L9 earnings per share for the last quarter are -0.80 EUR whereas the estimation was -0.86 EUR which accounts for 7.40% surprise. Company revenue for the same period amounts to 115.14 M EUR despite the estimated figure of 114.57 M EUR. Estimated earnings per share for the next quarter are -0.65 EUR, and revenue is expected to reach 141.05 M EUR. Also watch annual changes over time to get a bigger picture of 2L9 earnings per share and revenue dynamics.